Literature DB >> 8727813

The incidence of surgical complications is similar in good and poor grade patients undergoing repair of ruptured anterior circulation aneurysms: a retrospective review of 355 patients.

P D Le Roux1, J P Elliot, D W Newell, M S Grady, H R Winn.   

Abstract

To determine how clinical grade after subarachnoid hemorrhage impacts operative characteristics and the incidence of intra- and postoperative surgical complications, we retrospectively compared the surgical management of all good grade (n = 224) and poor grade (n = 131) patients who suffered ruptured anterior circulation aneurysms between 1983 and 1993. The majority of good grade (74.2%) and poor grade (89.8%) patients underwent surgery < 3 days after subarachnoid hemorrhage. The results in this series demonstrate that severe cerebral swelling, often secondary to intracerebral hemorrhage, was significantly more frequent in poor grade patients. The incidence of complications, such as failure to occlude the aneurysm, major vessel occlusion, intraoperative aneurysm rupture, or surgical contusion, however, was similar in poor grade and good grade patients. We conclude, therefore, that except for severe cerebral swelling associated with intracerebral hemorrhage, the risk of surgical complications is similar in good and poor grade patients undergoing surgical repair of ruptured anterior circulation aneurysms.

Entities:  

Mesh:

Year:  1996        PMID: 8727813     DOI: 10.1097/00006123-199605000-00006

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  9 in total

1.  Decompressive craniectomy in aneurysmal subarachnoid hemorrhage: relation to cerebral perfusion pressure and metabolism.

Authors:  Alexandra Nagel; Daniela Graetz; Peter Vajkoczy; Asita S Sarrafzadeh
Journal:  Neurocrit Care       Date:  2009-08-28       Impact factor: 3.210

2.  Impact of cardio-pulmonary and intraoperative factors on occurrence of cerebral infarction after early surgical repair of the ruptured cerebral aneurysms.

Authors:  Jong-Yun Chong; Dong-Won Kim; Cheol-Su Jwa; Hyeong-Joong Yi; Yong Ko; Kwang-Myung Kim
Journal:  J Korean Neurosurg Soc       Date:  2008-02-20

3.  Anterior Communicating Artery Aneurysm Surgery through the Orbitopterional Approach: Long-Term Follow-Up in a Series of 75 Consecutive Patients.

Authors:  Norberto Andaluz; Mario Zuccarello
Journal:  Skull Base       Date:  2008-07

4.  Factors and outcomes associated with ultra-early surgery for poor-grade aneurysmal subarachnoid haemorrhage: a multicentre retrospective analysis.

Authors:  Bing Zhao; Yuanli Zhao; Xianxi Tan; Yong Cao; Jun Wu; Ming Zhong; Shuo Wang
Journal:  BMJ Open       Date:  2015-04-15       Impact factor: 2.692

5.  Factors Influencing 1-year Functional Outcome after Surgery in Aneurysmal Subarachnoid Hemorrhage Patients: A Single-center Series.

Authors:  I-Sorn Phoominaonin; Somkiat Wongsuriyanan
Journal:  Asian J Neurosurg       Date:  2021-09-14

6.  How useful is the 3-dimensional, surgeon's perspective-adjusted visualisation of the vessel anatomy during aneurysm surgery? A prospective clinical trial.

Authors:  Veit Rohde; Franz-Josef Hans; Lothar Mayfrank; Stephan Dammert; Joachim M Gilsbach; Volker A Coenen
Journal:  Neurosurg Rev       Date:  2007-05-05       Impact factor: 2.800

7.  A Multicenter prospective study of poor-grade aneurysmal subarachnoid hemorrhage (AMPAS): observational registry study.

Authors:  Bing Zhao; Xianxi Tan; Hua Yang; Kuang Zheng; Zequn Li; Ye Xiong; Ming Zhong
Journal:  BMC Neurol       Date:  2014-04-17       Impact factor: 2.474

8.  Factors affecting outcome in poor grade subarachnoid haemorrhage: An institutional study.

Authors:  Sannepaneni Kranthi; Barada P Sahu; Purohit Aniruddh
Journal:  Asian J Neurosurg       Date:  2016 Oct-Dec

Review 9.  Anterior Communicating Artery Aneurysms: Anatomical Considerations and Microsurgical Strategies.

Authors:  Junhui Chen; Mingchang Li; Xun Zhu; Yan Chen; Chunlei Zhang; Wenwen Shi; Qianxue Chen; Yuhai Wang
Journal:  Front Neurol       Date:  2020-09-08       Impact factor: 4.003

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.